AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.37
+0.14 (1.52%)
At close: Oct 24, 2025, 4:00 PM EDT
9.41
+0.04 (0.43%)
After-hours: Oct 24, 2025, 7:04 PM EDT
AdaptHealth Market Cap
AdaptHealth has a market cap or net worth of $1.24 billion as of October 24, 2025. Its market cap has decreased by -7.31% in one year.
Market Cap
1.24B
Enterprise Value
3.12B
1-Year Change
-7.31%
Ranking
Category
Stock Price
$9.37
Market Cap Chart
Since November 11, 2019, AdaptHealth's market cap has increased from $386.84M to $1.24B, an increase of 220.61%. That is a compound annual growth rate of 21.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 1.24B | -1.02% |
| Dec 31, 2024 | 1.25B | 27.33% |
| Dec 29, 2023 | 984.09M | -62.00% |
| Dec 30, 2022 | 2.59B | -19.93% |
| Dec 31, 2021 | 3.23B | 20.61% |
| Dec 31, 2020 | 2.68B | 506.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |